Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.
Event Date |
Mon Nov 9 CST - Wed Nov 11 CST (about 4 years ago)
In your timezone (EST): Mon Nov 9 4:00am - Wed Nov 11 4:00am |
Location |
Jing An Shangri-La, West Shanghai
1218 Yan'an Middle Rd, Jing'an, Shanghai, China, 200040 |
Region | APAC |
China In The World: A program focused on what China must do to stand alongside the world’s leaders in the innovation ecosystem.
Six years ago, the first China Healthcare Summit asked how the nation would build the “Bridge to Innovation.” In 2019, we examine how China is now actually building the Bridge to Global Healthcare. A full two-day program highlighted by dialog among China-facing biotech innovators and their globally-facing Chinese counterparts.
The China Summit is a VIP-only event for busy biopharma and life sciences executives and investors to get a first-hand look at the innovation, business and policy transformations taking place in China. The conference is THE place to meet the right Chinese investors and partners in an intimate setting.
The China Summit agenda is developed by an Organizing Committee that includes China industry KOLs and the BioCentury editorial team. Simultaneous translation is provided in all strategic sessions.
2020 Speakers
Jun Bao, Ph.D.
President & CEO, Impact Therapeutics
Joshua Berlin
Executive Director, New Ventures, Biocentury
Karen Bernstein, Ph.D.
Chairman, Biocentury
Tony Chen, J.D.
Partner, Jones Day
David Flores
President & CEO, Biocentury
Simone Fishburn, Ph.D.
Vice President and Executive Editor, Biocentury
Tina Hou
Partner, Shanghai, Mckinsey & Co.
Kewen Jin, M.D.
Managing Partner, Serica Capital
Franck Le Deu
Senior Partner & Head of Greater China Healthcare Practice, Mckinsey & Co.
Victor Shi, Ph.D.
Chairman, Bayhelix, and CEO, Adicon Clinical Laboratories Inc.
Steve Yang, Ph.D.
EVP, Chief Business Officer,Wuxi Apptec
Debra Yu, M.D.
President & Chief Business Officer, Lianbio
2020 Partners
INSIGHTS PARTNER:
• McKinsey & Company
SUPPORTER:
• Lychee Group